Summary and Info
An in depth review of our latest understanding of the molecular events that regulate cell death and those molecules that provide targets for developing agonists or antagonists to modulate death signaling for therapeutic purposes. The authors focus on the extrinsic system of death receptors, their regulation and function, and their abnormalities in cancer. Topics of particular interest include resistance to apoptosis, TRAIL signaling, death receptors in embryonic development, mechanisms of caspase activation, and death receptor mutations in cancer. Additional chapters address death signaling in melanoma, synthetic retinoids and death receptors, the role of p53 in death receptor regulation, immune suppression of cancer, and combination therapy with death ligands.
More About the Author
Wafik El-Deiry, MD, PhD, is a Professor of Medicine and Deputy Director of Translational Research at Fox Chase Cancer Center, where he is also Co-Leader of the Molecular Therapeutics Program.
Review and Comments
Rate the Book
Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development) 0 out of 5 stars based on 0 ratings.